中国—东盟区域医药交易（集采）平台单笔交易金额突破千万元

Group 1 - The China-ASEAN Regional Pharmaceutical Trading Platform has successfully completed a single transaction exceeding 10 million yuan, marking a significant milestone since its operation began in January 2025 [1] - The platform has attracted 224 leading domestic pharmaceutical companies, showcasing 1,020 types of drugs and 2,418 categories of medical consumables, establishing a robust supply system for quality pharmaceuticals [1] - The platform has received procurement demands for over 170 types of pharmaceutical consumables from foreign buyers in countries such as Vietnam, Russia, Mali, and Thailand, indicating effective supply-demand matching [1] Group 2 - The platform has significantly improved the efficiency of cross-border pharmaceutical cooperation, reducing coordination time from months to weeks or even days, ensuring stable supply of high-quality drugs to Thai patients [2] - The platform is expected to facilitate a "worry-free, efficient, and win-win" cross-border channel for companies, promoting deeper collaboration with ASEAN partners [2] - The Guangxi Medical Insurance Department plans to enhance the platform's functionality by building a professional multilingual service platform to overcome language barriers and promote smoother cross-border trade [2]